Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Main Index

View All
IAD
ICL
IDH
IFN
IL
IMiDs
immunohistochemistry (IHC)
Immunotherapeutics anti-pD-1 and anti-pD-l1 characteristics CD8+ T effector cells signaling network
IMP
IND
infusion-related reaction (IRR) Multiple Myeloma as a Paradigm for Multi-Targeted Intervention Question 12.3
inhibitor of apoptosis (IAP)
inosine-5'-monophosphate dehydrogenase (IMPDH)
interferon (IFN) Monoclonal Antibodies Including Immunoconjugates and Cytokine-Directed Agents Answer 12.5
interleukin (IL)
IAP
ICOS
IDH1
IHC
IL-2
immune-related adverse effects (irAEs)
immunomodulatory drugs (IMiDs)
IMPDH
inducible T-cell costimulator (ICOS)
inosine-5'-monophosphate (IMP)
interferon regulatory factor 4 (IRF4)
interleukin-2 (IL-2) Monoclonal Antibodies Including Immunoconjugates and Cytokine-Directed Agents Question 12.5 Transplant-Related Agents
intermittent and rogen deprivation (IAD) Answer 10.2 Male Hormonal Therapies
interstrand crosslink (ICL)
intravenous (IV) Question 3.2 Question 3.6